UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer

Scientific reports, 2021-02, Vol.11 (1), p.4691-4691, Article 4691

2021

Volltextzugriff (PDF)

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199

Journal of clinical oncology, 2014-09, Vol.32 (27), p.2959-2966

2014

Volltextzugriff (PDF)

Targeting the Tumor-Tumor Microenvironment Crosstalk

Expert opinion on therapeutic targets, 2023, Vol.27 (6), p.447-457

2023

Volltextzugriff (PDF)

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study

Journal of clinical oncology, 2015-11, Vol.33 (33), p.3938-3944

2015

Volltextzugriff (PDF)

Artificial intelligence in breast pathology – dawn of a new era

NPJ breast cancer, 2023-01, Vol.9 (1), p.5-5, Article 5

Badve, Sunil S.

2023

Volltextzugriff (PDF)

ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting

Journal of thoracic oncology, 2014-05, Vol.9 (5), p.596-611

2014

Volltextzugriff (PDF)

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer

Clinical cancer research, 2018-06, Vol.24 (12), p.2851-2858

2018

Volltextzugriff (PDF)

Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database

Journal of thoracic oncology, 2018-03, Vol.13 (3), p.436-446

2018

Volltextzugriff (PDF)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers

Breast cancer research : BCR, 2019-08, Vol.21 (1), p.87-87, Article 87

2019

Volltextzugriff (PDF)

A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas

British journal of cancer, 2016-02, Vol.114 (4), p.477-484

2016

Volltextzugriff (PDF)

Is conservative management of ductal carcinoma in situ risky?

NPJ breast cancer, 2022-04, Vol.8 (1), p.55-55, Article 55

2022

Volltextzugriff (PDF)

Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer

PloS one, 2018-10, Vol.13 (10), p.e0204658-e0204658

2018

Volltextzugriff (PDF)

A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study

Frontiers in oncology, 2021-09, Vol.11, p.736620-736620

2021

Volltextzugriff (PDF)

Spatially variant immune infiltration scoring in human cancer tissues

NPJ precision oncology, 2022-09, Vol.6 (1), p.60-60, Article 60

2022

Volltextzugriff (PDF)

Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2473-2481

2008

Volltextzugriff (PDF)

The utility of immunostaining for NUT, GAGE7 and NY-ESO-1 in the diagnosis of spermatocytic seminoma

Histopathology, 2014-07, Vol.65 (1), p.35-44

2014

Volltextzugriff (PDF)

Ductal carcinoma in situ of breast: update 2019

Pathology, 2019-10, Vol.51 (6), p.563-569

2019

Volltextzugriff (PDF)

Cardiovascular disease in thymic cancer patients

Frontiers in cardiovascular medicine, 2024-09, Vol.11, p.1393631

2024

Volltextzugriff (PDF)

Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer

NPJ breast cancer, 2021-03, Vol.7 (1), p.29-7, Article 29

2021

Volltextzugriff (PDF)

A predictor of response in HER2+ breast cancer—at last

JNCI : Journal of the National Cancer Institute, 2023-03, Vol.115 (3), p.242-245

2023

Volltextzugriff (PDF)

Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130

JNCI : Journal of the National Cancer Institute, 2022-05, Vol.114 (5), p.664-675

2022

Volltextzugriff (PDF)

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

The New England journal of medicine, 2019-06, Vol.380 (25), p.2395-2405

2019

Volltextzugriff (PDF)

Intraoperative assessment of axillary sentinel lymph nodes by telepathology

Breast cancer research and treatment, 2023-12, Vol.202 (3), p.423-434

2023

Volltextzugriff (PDF)

Triple Negative Breast Cancers: An Obsolete Entity?

Clinical breast cancer, 2024-01, Vol.24 (1), p.1-6

2024

Volltextzugriff (PDF)

1 – 25 von 725

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(586)
Mit Volltextzugriff
(649)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(725)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199

Targeting the Tumor-Tumor Microenvironment Crosstalk

Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study

Artificial intelligence in breast pathology – dawn of a new era

ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer

Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers

Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial)

A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas

Is conservative management of ductal carcinoma in situ risky?

Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer

A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study

Spatially variant immune infiltration scoring in human cancer tissues

Estrogen- and Progesterone-Receptor Status in ECOG 2197: Comparison of Immunohistochemistry by Local and Central Laboratories and Quantitative Reverse Transcription Polymerase Chain Reaction by Central Laboratory

The utility of immunostaining for NUT, GAGE7 and NY-ESO-1 in the diagnosis of spermatocytic seminoma

Ductal carcinoma in situ of breast: update 2019

Cardiovascular disease in thymic cancer patients

Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer

A predictor of response in HER2+ breast cancer—at last

Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130

Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer

Intraoperative assessment of axillary sentinel lymph nodes by telepathology

Triple Negative Breast Cancers: An Obsolete Entity?

Suchergebnisse filtern